Table 1.
Characteristics | Total N = 529 (%) | No primary tumor resection N = 299 (%) | Primary tumor resection N = 230 (%) | P a |
---|---|---|---|---|
Age (y) | ||||
20‐39 | 34 (6.4) | 2 (0.7) | 32 (13.9) | <0.001 |
40‐59 | 219 (41.4) | 119 (39.8) | 100 (43.5) | |
60‐79 | 237 (44.8) | 147 (49.2) | 90 (39.1) | |
80+ | 39 (7.4) | 31 (10.4) | 8 (3.5) | |
Race | ||||
White | 355 (67.1) | 213 (71.2) | 142 (61.7) | <0.001 |
Black | 80 (15.1) | 54 (18.1) | 26 (11.3) | |
Other | 94 (17.8) | 32 (10.7) | 62 (27.0) | |
Sex | ||||
Male | 418 (79.0) | 248 (82.9) | 170 (73.9) | 0.011 |
Female | 111 (21.0) | 51 (17.1) | 60 (26.1) | |
Year | ||||
2004‐2008 | 282 (53.3) | 169 (56.5) | 113 (49.1) | 0.091 |
2009‐2013 | 247 (46.7) | 130 (43.5) | 117 (50.9) | |
Tumor size | ||||
<3 cm | 32 (6.0) | 16 (5.4) | 16 (7.0) | <0.001 |
3‐4.9 cm | 72 (13.6) | 38 (12.7) | 34 (14.8) | |
5‐10 cm | 163 (30.8) | 89 (29.8) | 74 (32.2) | |
>10 cm | 126 (23.8) | 49 (16.4) | 77 (33.5) | |
Unknown | 136 (25.7) | 107 (35.8) | 29 (12.6) | |
Stageb | ||||
IVa | 152 (28.7) | 61 (20.4) | 91 (39.6) | <0.001 |
IVb | 377 (71.3) | 238 (79.6) | 139 (60.4) | |
AFP | ||||
Negative | 92 (17.4) | 30 (10.0) | 62 (27.0) | <0.001 |
Positive | 295 (55.8) | 178 (59.5) | 117 (50.9) | |
Unknown | 142 (26.8) | 91 (30.4) | 51 (22.2) | |
Primary tumor number | ||||
Single | 173 (32.7) | 84 (28.1) | 89 (38.7) | 0.008 |
Multiple | 159 (30.1) | 88 (29.4) | 71 (30.9) | |
Unknown | 197 (37.2) | 127 (42.5) | 70 (30.4) | |
Vascular invasion | ||||
No | 175 (33.1) | 92 (30.8) | 83 (36.1) | 0.218 |
Yes | 127 (24.0) | 69 (23.1) | 58 (25.2) | |
Unknown | 227 (42.9) | 138 (46.2) | 89 (38.7) | |
Extrahepatic extension | ||||
No | 393 (74.3) | 216 (72.2) | 177 (77.0) | <0.001 |
Yes | 77 (14.6) | 34 (11.4) | 43 (18.7) | |
Unknown | 59 (11.2) | 49 (16.4) | 10 (4.3) | |
Radiotherapy | ||||
No | 461 (87.1) | 258 (86.3) | 203 (88.3) | 0.777 |
Yes | 65 (12.3) | 39 (13.0) | 26 (11.3) | |
Unknown | 3 (0.6) | 2 (0.7) | 1 (0.4) |
χ 2 test.
AJCC, American Joint Committee on Cancer (7th edition).